MLEC Moolec Science S.A.
USHealthcareAs of 2026-07-10 16:00
Why MLEC matters now
Moolec Science S.A. (MLEC) is a US stock in Healthcare. The latest InvestLog snapshot shows $7.33 with +0.00% on the session and $5.3M in market capitalization; recent performance reads 1-month +9.07% and YTD +114.14%.
The latest financial table shown here is FY 2024, with revenue of $333.6M, net income of $-111.5M, and EPS of $-258.75. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -506.8%.
The latest indexable market news headline is "Moolec Science Successfully Completes 2026 GLASO Commercial Planting Campaign in the United States" from Accesswire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $45.00; recent insider activity includes Core Daniel Joaquin filing . These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.05
P/S
0.02
EV/EBITDA
-3.65
DCF Value
$3,180.96
FCF Yield
-506.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
34.2%
Operating Margin
-3.1%
Net Margin
-33.4%
ROE
376.8%
ROA
-54.4%
ROIC
-5.3%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| FY 2024 | $333.6M | $-111.5M | $-258.75 |
| Q2 2024 | $2.6M | $-2.4M | $-0.90 |
| Q1 2024 | $1.6M | $-1.9M | $-0.75 |
| Q4 2023 | $1.5M | $-2.5M | $-1.05 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$45.00
Target (Median)
$45.00
Target Range
$45.00 - $45.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Biotechnology
Country
LU
Exchange
—
Beta
0.27
Moolec Science S.A. is an innovative biotechnology firm specializing in the development of plant-grown animal proteins. Leveraging a transformative method called Molecular Farming, the company is poised to disrupt the alternative protein market. Their product lines and research and development efforts capitalize on the inherent agricultural benefits of select host crops, such as soybeans and peas. Globally, Moolec maintains operations across the United States, Europe, and South America. Established in 2008, the company is headquartered in Luxembourg.